S. Yea

发表

Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo.

Derek Y. Chiang, V. Mazzaferro, S. Friedman, 2009, Journal of hepatology.

Pivotal role of mTOR signaling in hepatocellular carcinoma.

Derek Y. Chiang, M. Meyerson, V. Mazzaferro, 2008, Gastroenterology.

Krüppel-like Factor-6 Promotes Preadipocyte Differentiation through Histone Deacetylase 3-dependent Repression of DLK1*

S. Friedman, J. Friedman, G. Narla, 2005, Journal of Biological Chemistry.

Functional linkage of cirrhosis‐predictive single nucleotide polymorphisms of toll‐like receptor 4 to hepatic stellate cell responses

Olivia T. Abar, S. Friedman, J. Sninsky, 2009, Hepatology.

Downregulation of KLF6 is an early event in hepatocarcinogenesis, and stimulates proliferation while reducing differentiation.

S. Thorgeirsson, V. Mazzaferro, S. Friedman, 2007, Journal of hepatology.

Spatial characterization and quantification of CD40 expression across cancer types

D. Rimm, A. Psyrri, F. Ahmed, 2023, BMC Cancer.

Regulation of Kruppel-like factor 6 tumor suppressor activity by acetylation.

S. Friedman, J. Martignetti, G. Narla, 2005, Cancer research.

Ras promotes growth by alternative splicing-mediated inactivation of the KLF6 tumor suppressor in hepatocellular carcinoma.

S. Friedman, J. Llovet, J. Martignetti, 2008, Gastroenterology.

Burkitt Lymphoma and MYC: What Else Is New?

J. Said, M. Lones, Steven Yea, 2014, Advances in anatomic pathology.

A DDX5 S480A Polymorphism Is Associated with Increased Transcription of Fibrogenic Genes in Hepatic Stellate Cells*

S. Friedman, J. Sninsky, D. Mann, 2009, The Journal of Biological Chemistry.

Pivotal role of mTOR signaling in hepatocellular carcinoma.

Derek Y. Chiang, M. Meyerson, V. Mazzaferro, 2008, Gastroenterology.

polymorphism and Helicobacter pylori cagA subtype infection

Y. J. Lee, W. Jang, K. Paik, 2001 .